Not applicableActive Not RecruitingNCT06380335What this trial is testingStudy in Patients With Decompensated Liver CirrhosisWho this might be right forLiver Cirrhosis Resolution Therapeutics Limited 24
Large-scale testing (Phase 3)Not Yet RecruitingNCT06263816What this trial is testingEffect of Long-term Carvedilol to Prevent Decompensation or Death in Patients With Asymptomatic Child-Pugh A5 to B8 Cirrhosis and Clinically Significant Portal Hypertension: a Multicenter Double-blind Randomized Control TrialWho this might be right forAsymptomatic CirrhosisClinically Significant Portal Hypertension University Hospital, Tours 290
Large-scale testing (Phase 3)Study completedNCT05563389What this trial is testingStatin Impact on Hepatic DecompensationWho this might be right forQuality of Lifethe Incidence of Whole Complications Resultant From Decompensated Liver Tanta University 100
Not applicableStudy completedNCT06344364What this trial is testingDigital Pathology and AI for Liver Outcomes in MASLDWho this might be right forMetabolic Dysfunction-associated Steatotic Liver Disease PharmaNest, Inc 1,241
Not applicableStudy completedNCT06855056What this trial is testingValidation of New Prognostic Biomarkers in Patients With Decompensated CirrhosisWho this might be right forLiver CirrhosisDecompensated Cirrhosis of Liver European Foundation for Study of Chronic Liver Failure 189
Not applicableUnknownNCT05181332What this trial is testingPredictive Models of Hepatic Decompensation and Survival Outcomes in Pediatric Patients With CirrhosisWho this might be right forCirrhosisBiliary AtresiaCholedochal Cyst+4 more West China Hospital 400
Not applicableStudy completedNCT07687758What this trial is testingNon-Invasive Risk Stratification for Hepatocellular Carcinoma in HCV-Related Compensated Advanced Chronic Liver Disease Following Sustained Virological Response: Validation of the aMAP ScoreWho this might be right forHepatitis C Virus InfectionCompensated Advanced Chronic Liver DiseaseHepatocellular Carcinoma (HCC) Siriraj Hospital 571
Large-scale testing (Phase 3)Active Not RecruitingNCT03900429What this trial is testingEvaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and FibrosisWho this might be right forNASH - Nonalcoholic Steatohepatitis Madrigal Pharmaceuticals, Inc. 1,759
Not applicableLooking for participantsNCT06431919What this trial is testingCarvedilol + Simvastatin vs. Carvedilol Alone for Cirrhosis and Cirrhotic Cardiomyopathy and Impact on Hepatic Decompensation and SurvivalWho this might be right forDecompensated CirrhosisCirrhotic CardiomyopathyCirrhosis, Liver+2 more Post Graduate Institute of Medical Education and Research, Chandigarh 260
Not applicableStudy completedNCT02084160What this trial is testingPrediction Value of the BreathID 13C-Methacetin Breath Test for Hepatic DecompensationWho this might be right forChronic Liver Disease Meridian Bioscience, Inc. 579
Testing effectiveness (Phase 2)Ended earlyNCT06987968What this trial is testingSee if an Investigational Medicine Called VS-01 Can Help and How Safe it is in the Treatment of Patients With Overt Hepatic EncephalopathyWho this might be right forHepatic EncephalopathyAcute on Chronic Liver Failure (ACLF)Decompensated Cirrhosis Genfit 3
Not applicableEnded earlyNCT00375011What this trial is testingBreath Test to Assess Hepatic Metabolic Reserve and to Predict Hepatic Decompensation in CirrhoticsWho this might be right forCirrhosis Meridian Bioscience, Inc. 200
Large-scale testing (Phase 3)UnknownNCT01560845What this trial is testingABMSC Infusion Through Hepatic Artery in Portal Hypertension Surgery for the Treatment of Liver CirrhosisWho this might be right forLiver CirrhosisPortal HypertensionHepatic Decompensation+1 more Wenzhou Medical University 50
Not applicableLooking for participantsNCT07607769What this trial is testingMONTEROSA - Italian Multicenter Observational Study to Evaluate Time to Clinical Hepatic Decompensation, Quality of Life, Effectiveness, and Safety of Tremelimumab Plus Durvalumab in Patients With Advanced or Unresectable Hepatocellular Carcinoma Who Have Received no Prior Systemic Treatment.Who this might be right forHepatocellular Carcinoma AstraZeneca 200
Large-scale testing (Phase 3)Temporarily pausedNCT02271295What this trial is testingImpact on Morbidity and Mortality of Prophylactic Dosing of Low Molecular Heparin in Child-Pugh B Cirrhotic PatientsWho this might be right forCirrhosis Assistance Publique - Hôpitaux de Paris 16
Large-scale testing (Phase 3)Active Not RecruitingNCT05297448What this trial is testingEvaluation of Rifaximin SSD for Delaying Encephalopathy Decompensation in Patients With CirrhosisWho this might be right forHepatic Encephalopathy Bausch Health Americas, Inc. 466
Not applicableStudy completedNCT00341705What this trial is testingThe Second Multicenter Hemophilia Cohort StudyWho this might be right forLiver DecompensationHepatocellular CarcinomaNon-Hodgkin Lymphoma National Cancer Institute (NCI) 2,565
Testing effectiveness (Phase 2)UnknownNCT04620148What this trial is testingTAK-242 in Patients With Acute Alcoholic HepatitisWho this might be right forAcute-On-Chronic Liver Failure Akaza Bioscience Ltd 100
Large-scale testing (Phase 3)Ended earlyNCT02455167What this trial is testingReversal of Hepatic Impairment in Patients With Hepatitis C Virus (HCV) and Early Decompensation of CirrhosisWho this might be right forHepatitis C University of Colorado, Denver 9
Not applicableStudy completedNCT05100485What this trial is testingAlgorithm to Stratify Clinical Decompensation Risk in Patients With Compensated Advanced Chronic Liver Disease (CHESS2108)Who this might be right forCompensated Advanced Chronic Liver Disease Hepatopancreatobiliary Surgery Institute of Gansu Province 1,000